Diclofenac Sodium Injection 3mL:75mg

Diclofenac Sodium Injection
  • Dosage: Diclofenac Sodium 75mg
  • Volume:  3 ml Ampoule
  • Packaging: 3 ml ampoule * 10/tray/box*300 carton
  • Shelf Life: 36 months 

Click to add this item to cart.

Product Description

Product NameDiclofenac Sodium Injection
Specification75mg/3mL (25mg/mL)
Dosage FormSterile Solution for Injection / Infusion
Active IngredientDiclofenac Sodium
Pharmacological ClassNon-Steroidal Anti-Inflammatory Drug (NSAID)
Route of AdministrationDeep intramuscular injection, or intravenous infusion (after dilution). NOT for intravenous bolus injection.
Packaging3mL amber glass ampoule
StorageStore below 25°C, protected from light. Do not freeze. Keep ampoule in outer carton until use.
Shelf Life36 months (unopened)

Product Overview

Diclofenac Sodium Injection 75mg/3mL is a sterile, aqueous solution of diclofenac sodium intended for parenteral administration. Each 3mL ampoule contains 75mg of diclofenac sodium, providing a concentration of 25mg/mL. Diclofenac sodium is a non-steroidal anti-inflammatory drug (NSAID) with pronounced analgesic, anti-inflammatory, and antipyretic activity, widely used in the management of pain and inflammatory conditions.

Diclofenac Sodium Injection 3mL:75mg: What the Published Guidance Says

The three non-opioid analgesics named on the WHO Model List — paracetamol, ibuprofen and acetylsalicylic acid — in the full range of oral, rectal and injectable presentations, plus the wider NSAID family.

Before Diclofenac Sodium Injection 3mL:75mg is quoted, we confirm the monograph, the strength on the artwork and the release testing required by your market — the points summarised here.

We quote these sources rather than paraphrase them loosely, because the detail matters commercially for Diclofenac Sodium Injection 3mL:75mg. Where your national list differs from the WHO listing, the national list governs what may be supplied and promoted locally.

Diclofenac Sodium Injection 3mL:75mg: Specification, Pack & Documentation Summary

Product NameDiclofenac Sodium Injection
Specification75mg/3mL (25mg/mL)
Dosage FormSterile Solution for Injection / Infusion
Active IngredientDiclofenac Sodium
Pharmacological ClassNon-Steroidal Anti-Inflammatory Drug (NSAID)
Route of AdministrationDeep intramuscular injection, or intravenous infusion (after dilution). NOT for intravenous bolus injection.
StorageStore below 25°C, protected from light. Do not freeze. Keep ampoule in outer carton until use.
Therapeutic groupAnalgesics & NSAIDs — Analgesics & NSAIDs
ManufacturerSinophare Bio-technology Co., Ltd. (GMP, China)
Documentation suppliedCOA, HPLC/GC data, stability data, dossier package

The same therapeutic range is supplied in several presentations, so one purchase order can cover a mixed requirement: Piroxicam Injection 1ml:10mg, Lysine Acetylsalicylate Injection 7ml:900mg Ampoule, Paracetamol Injection 500mg/5mL, Ibuprofen Suppository 50mg, Indomethacin Suppository 100mg, Naproxen Suppositories 250mg, Paracetamol Suppository 150mg, Diclofenac Sodium 50mg.

How Diclofenac Sodium Injection 3mL:75mg Is Tested and Released

Products are manufactured and tested against USP, EP, BP and CP monographs, with incoming raw-material inspection, in-process monitoring and full finished-product testing.

Every batch of Diclofenac Sodium Injection 3mL:75mg is tested to the monograph stated on the purchase order. Where a monograph is silent on the presentation, we agree a written specification with you in advance and reference it on the certificate of analysis.

Standardised GMP production workshops with an independent R&D laboratory and a complete quality-inspection centre.

Release testing on this presentation is built around:

  • Testing for uniformity of dosage units
  • Testing for water content and pH where applicable
  • Testing for sterility and bacterial endotoxins (parenterals and ophthalmics)
  • Testing for microbial limits and preservative efficacy (multi-dose presentations)
  • Testing for heavy metals and elemental impurities
  • Testing for packaging integrity and seal testing

COA, HPLC and GC data, DMF and dossier packages, plus registration support documents for national marketing-authorisation filings.

How Diclofenac Sodium Injection 3mL:75mg Is Packed, Labelled and Shipped

  • Pack size: 3mL amber glass ampoule. Non-standard pack sizes can be quoted against your artwork.
  • Storage: Store below 25°C, protected from light. Do not freeze. Keep ampoule in outer carton until use..
  • Shelf life: 36 months (unopened). Stability data for the marketed pack is included in the dossier.
  • Labelling: artwork can be produced in English, Arabic, French, Russian and Spanish, with your own brand and language mix, subject to the labelling rules of the destination market.
  • Export: GMP certificate, COA, certificate of origin, packing list and, where required, the free-sale or marketing authorisation certificate from the country of manufacture.

Regulatory Support for Diclofenac Sodium Injection 3mL:75mg

Documents for Diclofenac Sodium Injection 3mL:75mg are issued by Sinophare Bio-technology Co., Ltd. — DML Number Jin20160068 (medicines) and Jin20160069 (paracetamol API).. Keeping one legal manufacturer across the COA, the GMP certificate and the registration file avoids assessment queries later.

  • Batch manufacturing and packaging records released for inspection on request during supplier audits.
  • Re-test or renewal support when the marketing authorisation comes up for variation or renewal.
  • CTD dossier modules 1–5 in editable and PDF form, with the finished-product and API sections cross-referenced.
  • Site Master File and GMP certificate for the manufacturing workshops.
  • Method validation, stability protocol and the shelf-life justification for the marketed pack.

The context for Diclofenac Sodium Injection 3mL:75mg is its place among non-opioid analgesics and NSAIDs named in the WHO Model List. Listing status informs how programmes specify a product; it is not a substitute for the import licence or marketing authorisation of the destination country.

Questions We Are Asked About Diclofenac Sodium Injection 3mL:75mg

What pack size is available for Diclofenac Sodium Injection 3mL:75mg?

This presentation is normally supplied as 3mL amber glass ampoule. Where your market requires a different count, bottle or carton, we quote to your artwork and extend the stability file to the new pack.

What documentation comes with a shipment of Diclofenac Sodium Injection 3mL:75mg?

Shipments are accompanied by a certificate of analysis covering identification, assay and related substances, together with the marketed-pack stability data and the manufacturing site GMP certificate. Shelf life: 36 months.

Does the batch documentation for Diclofenac Sodium Injection 3mL:75mg support a registration filing?

Shipments are accompanied by a certificate of analysis covering identification, assay and related substances, together with the marketed-pack stability data and the manufacturing site GMP certificate. Shelf life: 36 months. The full CTD dossier and the authority assessment file are supplied as part of a registration order; routine shipments carry the COA and stability data only.

Is diclofenac on the WHO Essential Medicines List?

No. The non-opioid analgesics named in section 2.1 are acetylsalicylic acid, ibuprofen and paracetamol. We supply diclofenac sodium in injectable and capsule form for markets whose national lists include it.

Can you supply sustained-release or combination analgesics?

Yes — including compound presentations and sustained-release forms. Confirm the specific combination against your national registration before ordering.

Companion Products — Analgesics & NSAIDs

Browse the full Analgesics & NSAIDs range; all Injectables; the complete product catalogue.

Request a Quotation for Diclofenac Sodium Injection 3mL:75mg

For tenders and programme supply, send the line item, pack size, quantity and destination for Diclofenac Sodium Injection 3mL:75mg 75mg. We return a quotation with lead time, documentation list and sample availability in one response.

Request a quotation

Sources & Regulatory Notes

Reference information only. The published guidance summarised on this page is quoted for professional and regulatory-context purposes and does not constitute medical advice, a prescribing recommendation or a promotion of any product for a particular indication. Prescribing decisions must follow the approved product information and national treatment guidelines in the market of use.

<< return to products